Meningococcal vaccines in China-Reference-Cited by-同舟云学术

Meningococcal vaccines in China

Published:2021-02-10 Issue:7 Volume:17 Page:2197-2204
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Xu Yinghua¹,Li Yanan¹,Wang Shanshan¹,Li Maoguang¹,Xu Miao¹,Ye Qiang¹

Affiliation:

1. Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People’s Republic of China.

Funder

Key Technologies Research and Development Program

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1857201

Reference65 articles.

1. Invasive Meningococcal Disease in the 21st Century—An Update for the Clinician

2. Description and Nomenclature ofNeisseria meningitidisCapsule Locus

3. Increased Case‐Fatality Rate Associated with Outbreaks ofNeisseria meningitidisInfection, Compared with Sporadic Meningococcal Disease, in the United States, 1994–2002

4. Neisserial Molecular Adaptations to the Nasopharyngeal Niche

5. Neisseria meningitidis: Biology, Microbiology, and Epidemiology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among Neisseria meningitidis in China;Microorganisms;2024-02-27

2. Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China;Human Vaccines & Immunotherapeutics;2024-02-13

3. An Overview of Meningococcal Disease's Recent Diagnostic and Treatment Model;Cureus;2023-11-08

4. Long-Term Patterns of Meningitis Mortality: A Continual Downward Trend and a Vulnerable Infant Population — China, 1987–2021;China CDC Weekly;2023

5. A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine;Vaccine;2022-11